Related Experiment Video
Updated: Mar 29, 2026
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Somatic mtDNA variation is an important component of Parkinson's disease
Jonathan Coxhead1, Marzena Kurzawa-Akanbi1, Rafiqul Hussain1
1Mitochondrial Research Group, Institute of Genetic Medicine, University of Newcastle Upon Tyne, UK.
Abstract:
There is a growing body of evidence linking mitochondrial dysfunction, mediated either through inherited mitochondrial DNA (mtDNA) variation or mitochondrial proteomic deficit, to Parkinson's disease (PD). Yet, despite this, the role of somatic mtDNA point mutations and specifically point-mutational burden in PD is poorly understood. Here, we take advantage of recent technical and methodological advances to examine the role of age-related and acquired mtDNA mutation in the largest study of mtDNA in postmortem PD tissue to date. Our data show that PD patients suffer an increase in mtDNA mutational burden in, but no limited to, the substantia nigra pars compacta when compared to matched controls. This mutational burden appears increased in genes encoding cytochrome c oxidase, supportive of previous protein studies of mitochondrial dysfunction in PD. Accepting experimental limitations, our study confirms the important role of age-related mtDNA point mutation in the etiology of PD, moreover, by analyzing 2 distinct brain regions, we are able to show that PD patient brains are more vulnerable to mtDNA mutation overall.
Insights
Parkinson's disease (PD) is linked to mitochondrial DNA (mtDNA) mutations. This study found increased mtDNA mutational burden in PD brains, confirming mtDNA's role in PD etiology.
Area of Science:
- Neuroscience
- Genetics
- Mitochondrial Biology
Background:
- Mitochondrial dysfunction is implicated in Parkinson's disease (PD).
- The role of somatic mitochondrial DNA (mtDNA) point mutations and their burden in PD pathogenesis remains unclear.
- Previous studies suggest links between inherited mtDNA variations or proteomic deficits and PD.
Purpose of the Study:
- To investigate the role of age-related and acquired mtDNA point mutations in Parkinson's disease.
- To quantify mtDNA mutational burden in postmortem PD brain tissue.
- To determine if PD brains exhibit increased vulnerability to mtDNA mutations.
Main Methods:
- Analysis of mtDNA in postmortem brain tissue from PD patients and matched controls.
- Utilized advanced technical and methodological approaches for mtDNA mutation detection.
- Examined two distinct brain regions to assess differential mutation susceptibility.
Main Results:
- PD patients showed a significantly increased mtDNA mutational burden compared to controls, particularly in the substantia nigra.
- Elevated mutational burden was observed in genes encoding cytochrome c oxidase.
- PD brains demonstrated greater overall vulnerability to mtDNA mutations across analyzed regions.
Conclusions:
- Age-related mtDNA point mutations play a significant role in the etiology of Parkinson's disease.
- Increased mtDNA mutational burden is a feature of PD brains.
- PD pathogenesis involves heightened susceptibility to mtDNA mutations.
More Related Videos
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
Related Concept Videos
01:15Parkinson's Disease: Overview
02:59Animal Mitochondrial Genetics
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:37Neural Regulation